Search

Fisher & Paykel Healthcare Corp Ltd

Fermé

SecteurImmobilier

31.61 0.96

Résumé

Variation du prix de l'action

24h

Actuel

Min

31.49

Max

31.69

Chiffres clés

By Trading Economics

Revenu

224M

Ventes

1.3B

P/E

Moyenne du Secteur

55.982

83.358

Rendement du dividende

1.35

Marge bénéficiaire

17.496

Employés

7,384

EBITDA

654M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+25.49% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.35%

5.91%

Prochains Résultats

26 nov. 2025

Date du Prochain Détachement de Dividende

4 déc. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.6B

18B

Ouverture précédente

30.65

Clôture précédente

31.61

Sentiment de l'Actualité

By Acuity

29%

71%

25 / 189 Classement par Real estate

Fisher & Paykel Healthcare Corp Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 juin 2025, 22:48 UTC

Market Talk

Export Data Buoy Fisher & Paykel Healthcare Bull -- Market Talk

28 mai 2025, 22:28 UTC

Market Talk

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 avr. 2025, 02:01 UTC

Market Talk

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 févr. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 févr. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

Fisher & Paykel Healthcare Corp Ltd prévision

Objectif de Prix

By TipRanks

25.49% hausse

Prévisions sur 12 Mois

Moyen 39.24 AUD  25.49%

Haut 40.9 AUD

Bas 37.58 AUD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

5 ratings

3

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

25 / 189Classement par Immobilier

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
help-icon Live chat